The most frequent oncogenic driver in NSCLC is the Kirsten rat sarcoma viral oncogene (KRAS) present in up to 40% of all cases, and the most common mutations are G12C, G12V and G12D [15,16]. Here, KRAS is linked to non-small cell lung carcinoma.